These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. Isono M; Hoffmann MJ; Pinkerneil M; Sato A; Michaelis M; Cinatl J; Niegisch G; Schulz WA J Exp Clin Cancer Res; 2017 Jan; 36(1):1. PubMed ID: 28049532 [TBL] [Abstract][Full Text] [Related]
11. Frondoside A is a potential anticancer agent from sea cucumbers. Sajwani FH J Cancer Res Ther; 2019; 15(5):953-960. PubMed ID: 31603094 [TBL] [Abstract][Full Text] [Related]
12. Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. Liu CH; Chen CY; Huang AM; Li JH J Ethnopharmacol; 2011 Sep; 137(1):503-11. PubMed ID: 21708241 [TBL] [Abstract][Full Text] [Related]
13. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex. Schlütermann D; Skowron MA; Berleth N; Böhler P; Deitersen J; Stuhldreier F; Wallot-Hieke N; Wu W; Peter C; Hoffmann MJ; Niegisch G; Stork B Urol Oncol; 2018 Apr; 36(4):160.e1-160.e13. PubMed ID: 29276062 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells. Jin JO; Shastina VV; Shin SW; Xu Q; Park JI; Rasskazov VA; Avilov SA; Fedorov SN; Stonik VA; Kwak JY FEBS Lett; 2009 Feb; 583(4):697-702. PubMed ID: 19162021 [TBL] [Abstract][Full Text] [Related]
16. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts. Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966 [TBL] [Abstract][Full Text] [Related]
17. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma. Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553 [TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells. Fechner G; Perabo FG; Schmidt DH; Haase L; Ludwig E; Schueller H; Blatter J; Mller SC; Albers P Urology; 2003 Feb; 61(2):468-73. PubMed ID: 12597983 [TBL] [Abstract][Full Text] [Related]
19. Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Li X; Roginsky AB; Ding XZ; Woodward C; Collin P; Newman RA; Bell RH; Adrian TE Ann N Y Acad Sci; 2008 Sep; 1138():181-98. PubMed ID: 18837899 [TBL] [Abstract][Full Text] [Related]
20. Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma. Lin WC; Hsu FS; Kuo KL; Liu SH; Shun CT; Shi CS; Chang HC; Tsai YC; Lin MC; Wu JT; Kuo Y; Chow PM; Liao SM; Yang SP; Hong JY; Huang KH J Mol Med (Berl); 2018 Dec; 96(12):1307-1318. PubMed ID: 30288546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]